Molly Doyle and Eric Lindsey join Commonwealth Health Advisors

Commonwealth Health Advisors is delighted to announce the addition of two new partners to our firm – Molly Doyle and Eric Lindsey

With over 20 years’ experience in Population Health, Service Delivery and Digital Health, Molly has been a Product leader at Pfizer Health Solutions, Health Dialog, Welltok (Predilytics) and meQuilibrium. She has built an impressive track record of bringing new products to market through deep market research, collaborative design and development, and rapid testing and validation to create outstanding user experiences and value for customers. A veteran of 5 start-ups, Molly is known as a big picture thinker with rigorous execution skills who helps organizations mature and scale to drive long-term growth and profitability.

Eric is an executive and entrepreneur with a track record of delivering high levels of revenue in healthcare technology and pharmaceutical services. His extensive commercial leadership experience runs the gamut from small organizations and provider practices to pharmaceutical firms like Pfizer, Sanofi, and Novartis. As an executive with a growth focus, he has built and led commercial organizations for public and private companies including Stryker, IQVIA, and Patient Point. With a successful exit under his belt, Eric is also an investor and entrepreneur who advises many emerging companies with sales planning and execution.

We are exceptionally lucky to have both Molly and Eric join our team, bringing their considerable talents and experience to bear on behalf of our clients.

Commonwealth Health Advisors announces the completion of its 50th client engagement.

This significant milestone in the growth of our firm comes from our commitment to delivering executable strategies for businesses that are among the most respected in healthcare.  Since our inception in 2014, our management consulting firm has been working exclusively with healthcare IT and services companies.

Our engagements primarily begin with CEOs and boards looking to tune their business strategy for optimal market success—an exercise every great business conducts regularly. We assist executive management teams in establishing or re-defining product and market strategies and the execution plans that follow. Our proven approach employs an efficient and effective process that delivers new market-validated insights combined with pragmatic action plans.

We could not have achieved this fifty-client milestone without the top talent our firm is privileged to attract. Commonwealth Health Advisors now offers additional practices designed to support our clients in organizing and executing key business functions including business development, sales operations/enablement, strategic product marketing, product management, product development and client success.

We are excited as we embark on the journey toward our 100th-client milestone!

Visit us at www.cwhadvisors.com.

Commonwealth Health Advisors Expands Client Resources with Formally Launched Market Validation Board

The team at Commonwealth Health Advisors has operational experience in every facet of the healthcare industry; our expertise and go-to-market approach makes us unique. But what makes us truly powerful is our ability to leverage the experience and insights of our recently launched Market Validation Board, a peerless group of industry experts from leading health plans, health systems, employers, and healthcare IT product and services businesses, who have joined forces with our consultants to provide market insight, strategic direction and candid, market validated feedback to our clients.

How Commonwealth Does HIMSS

Commonwealth Health Advisors provides their pro tips on how to do HIMSS right. HIMSS 2016 is fast-approaching! Did you know that over 40,000 attendees will fill the exhibit hall housing over 1,300 vendor booths consuming space that totals the area of over 40 football fields?